1933 Industries Inc

OTCQB:TGIFF USA Drug Manufacturers - Specialty & Generic
Market Cap
$1.74 Million
Market Cap Rank
#34888 Global
#11381 in USA
Share Price
$0.00
Change (1 day)
-30.00%
52-Week Range
$0.00 - $0.01
All Time High
$1.06
About

1933 Industries Inc., together with its subsidiaries, engages in the cultivation, extraction, and production of cannabis products in the United States. It operates through AMA and Infused MFG segments. The company offers craft-style cannabis, branded flower, infused pre-rolls, full spectrum oils, distillates, and blends of terpenes; vaporizer products and boutique concentrate, such as shatter, cr… Read more

1933 Industries Inc (TGIFF) - Net Assets

Latest net assets as of October 2025: $-4.43 Million USD

Based on the latest financial reports, 1933 Industries Inc (TGIFF) has net assets worth $-4.43 Million USD as of October 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($16.20 Million) and total liabilities ($20.63 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-4.43 Million
% of Total Assets -27.35%
Annual Growth Rate N/A
5-Year Change -118.22%
10-Year Change N/A
Growth Volatility 103.87

1933 Industries Inc - Net Assets Trend (2015–2025)

This chart illustrates how 1933 Industries Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for 1933 Industries Inc (2015–2025)

The table below shows the annual net assets of 1933 Industries Inc from 2015 to 2025.

Year Net Assets Change
2025-07-31 $-4.60 Million +4.91%
2024-07-31 $-4.84 Million +8.13%
2023-07-31 $-5.26 Million -169.96%
2022-07-31 $7.52 Million -70.19%
2021-07-31 $25.23 Million +29.72%
2020-07-31 $19.45 Million -47.69%
2019-07-31 $37.19 Million +0.55%
2018-07-31 $36.98 Million +131.05%
2017-07-31 $16.01 Million +5546.83%
2016-07-31 $-293.88K -188.59%
2015-07-31 $331.71K --

Equity Component Analysis

This analysis shows how different components contribute to 1933 Industries Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 9871506000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (July 2025)

Component Amount Percentage
Other Components $94.16 Million %
Total Equity $-4.60 Million 100.00%

1933 Industries Inc Competitors by Market Cap

The table below lists competitors of 1933 Industries Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in 1933 Industries Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -3,534,217 to -4,598,140, a change of -1,063,923.
  • Net loss of 217,042 reduced equity.
  • Other factors decreased equity by 846,881.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-217.04K -4.72%
Other Changes $-846.88K -18.42%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares 1933 Industries Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-07-31 $0.00 $0.00 x
2016-07-31 $0.00 $0.00 x
2017-07-31 $0.11 $0.00 x
2018-07-31 $0.16 $0.00 x
2019-07-31 $0.13 $0.00 x
2020-07-31 $0.07 $0.00 x
2021-07-31 $0.06 $0.00 x
2022-07-31 $0.02 $0.00 x
2023-07-31 $-0.01 $0.00 x
2024-07-31 $-0.01 $0.00 x
2025-07-31 $-0.01 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently 1933 Industries Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -1.24%
  • • Asset Turnover: 1.04x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-42.92%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -49.25% 0.00% 0.00x 1.14x $-196.54K
2016 0.00% 0.00% 0.00x 0.00x $-3.65 Million
2017 -17.18% -265.41% 0.05x 1.19x $-4.33 Million
2018 -15.90% -46.20% 0.31x 1.12x $-9.52 Million
2019 -50.13% -104.03% 0.29x 1.65x $-22.53 Million
2020 -105.79% -180.08% 0.26x 2.29x $-23.58 Million
2021 -24.89% -54.03% 0.26x 1.74x $-9.07 Million
2022 -208.96% -142.02% 0.43x 3.40x $-18.66 Million
2023 0.00% -79.16% 0.94x 0.00x $-12.99 Million
2024 0.00% -5.90% 1.15x 0.00x $-788.58K
2025 0.00% -1.24% 1.04x 0.00x $242.77K

Industry Comparison

This section compares 1933 Industries Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
1933 Industries Inc (TGIFF) $-4.43 Million -49.25% N/A $1.61 Million
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million